Search
How to Identify AI Washing in Medical Technology M&A? Key Difficulties in Due Diligence of Digital Health AI Assets and Analysis of New FDA Regulations, Covering CDS Guidelines, NAMs, and Clinical Trial Innovation.
According to a Future Market Insights report, the global medical IoT market is expected to reach US$280.5 billion by 2026, increasing to US$1,164.8 billion by 2036, with a compound annual growth rate of 15.3%. Hardware accounts for 46%, telemedicine for 32%, and India is the fastest-growing market.
According to the latest report from Precedence Research, the global digital health market size is expected to grow from $420.08 billion in 2025 to $1.171 trillion by 2035, with a CAGR of 10.8%. AI, telemedicine, and wearable devices are driving the wave of healthcare digitalization, with Europe leading the global market.
This article reviews the evolution of digital health from early mobile health to the present, analyzes how technology is reshaping the healthcare industry, and looks forward to future trends in medical innovation in the AI era.
The global digital health market is expected to reach $2.19 trillion by 2034, with a compound annual growth rate of 22.5%. The North American market leads, with telehealth and AI as the main drivers.
Global digital therapeutics and AI medical device regulation are accelerating, with FDA and NMPA approval numbers hitting record highs and the industry facing new compliance challenges. This article analyzes regulatory strategies, clinical evidence, and market impact.
According to Market.us Media data, the global digital health market is expected to reach $2.19 trillion by 2034, with $287.8 billion in 2024, representing a compound annual growth rate of 22.5%. North America dominates the market, while Asia-Pacific is growing the fastest, with telemedicine, medical AI, and wearable devices becoming core drivers.
The global wearable medical device market is expected to reach $167.8 billion by 2035, with a compound annual growth rate of 14.2%. Driven by policy, technology, and capital, the healthcare industry is undergoing a transition from periodic checkups to continuous monitoring.
The digital health market is expected to grow from $287.8 billion in 2024 to $2.19 trillion by 2034, with a compound annual growth rate of 22.5%. North America leads with a 38.4% share, while Asia-Pacific is the fastest-growing region. Technological innovations such as AI, telemedicine, and wearable devices are reshaping the healthcare industry landscape. This article provides an in-depth analysis of market trends, regional dynamics, and future opportunities.
According to the report, the global wearable medical device market reached $44.5 billion in 2025, and is expected to grow to $167.8 billion by 2035, at a compound annual growth rate of 14.2%. CMS expanding reimbursement for remote monitoring, the EU's digital health strategy, and the miniaturization of biosensors are the main drivers.
XRHealth acquires digital therapeutics company Swing Therapeutics, integrating the FDA De Novo-authorized Stanza fibromyalgia treatment with its virtual clinic to build a cross-device XR chronic pain management platform, and achieving comprehensive reimbursement through Medicare and commercial insurance.
As GLP-1 drugs evolve from injectables to oral, multi-target, and RNA therapies, the entire metabolic disease treatment market is undergoing profound changes. This article analyzes the latest industry trends, key company strategies, and development directions over the next 3-5 years.